Timing of Everolimus Conversion After Liver Transplantation: Ever Early and Never Late

Liver Transpl. 2020 Nov;26(11):1395-1397. doi: 10.1002/lt.25881. Epub 2020 Oct 1.

Authors

Hani M Wadei¹, Andrew P Keaveny¹

Affiliation

¹ Division of Nephrology and Hypertension, Department of Transplantation, Department of Medicine, Mayo Clinic, Jacksonville, FL.

PMID: 32890436
DOI: 10.1002/lt.25881

No abstract available

Publication types

Editorial
Comment

MeSH terms

Calcineurin Inhibitors
Everolimus / adverse effects
Humans
Immunosuppressive Agents / adverse effects
Liver Transplantation* / adverse effects
Registries

Substances

Calcineurin Inhibitors
Immunosuppressive Agents
Everolimus